Divis Laboratories Ltd | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Alaunos Therapeutics USD 845K 162K 2024-12
Aurobindo Pharma INR 11.63B 310.9M 2025-03
Avita Medical AUD 21.23M 2.57M 2024-12
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.4B 10M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
IQVIA Holdings USD 509M 1000K 2025-06
Lupin INR 10.83B 817.5M 2025-06
Moderna USD 230M 18M 2025-06
Organon & Co USD 453M 33M 2025-06
Revvity USD 248.53M 1.19M 2025-06
Tectonic Therapeutic USD 4.84M 469K 2024-12
Tilray USD 72.38M 4.99M 2024-11
Viatris USD 928.7M 111.2M 2025-06
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12


Divis Laboratories Ltd Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.